Lux Capital
Lux Capital is a venture capital firm founded by Peter Hébert, Robert Paull, and Josh Wolfe[1] in 2000[2] . The firm, based in New York City with an office in Menlo Park, invests in emerging technologies in the physical and life sciences.[3][4]
Private | |
Industry | Venture capital |
Founded | 2000 |
Founders |
Peter Hébert Robert Paull Josh Wolfe |
Headquarters | New York, NY, Menlo Park, CA, United States |
Total assets | $700,000,000 |
Website | luxcapital.com |
About
Lux Capital is a venture firm based in New York City and Silicon Valley investing in counter-conventional, seed and early stage science and technology ventures. The firm manages $700 million in assets across four funds.[5] Lux founded strategic holdings in media, research and policy as proprietary sources of intelligence, access and influence – ensuring that portfolio companies are better connected, have deeper insight, and command industry leadership faster than their competition.The Lux Capital team has built more than 20 companies from scratch.[5]
In April 2011, former McKinsey Senior Partner Richard N. Foster and former CIA Director James Woolsey joined Lux Capital as venture partners.[6] In August 2012, former Pfizer Chairman and CEO Jeff Kindler joined Lux Capital as a venture partner.[7]
Portfolio companies
- 3Scan
- AltspaceVR
- BrightSky Labs
- Cambrios
- CloudMedx Inc
- Cerulean Pharma [NASDAQ:CERU]
- Crystal IS
- CyPhy Works
- Echodyne
- Everspin Technologies
- Experiment
- Genocea Biosciences [NASDAQ:GNCA]
- Gridco
- Halo Neuroscience
- Kala Pharmaceuticals
- Kurion
- Kymeta
- Kyruus
- Lensbricks
- Luxtera
- Matterport
- Moment
- Nanosys
- Orbital Insight
- Pager
- Plethora
- Planet Labs
- Nanosys
- Nervana Systems
- Scaled Inference
- Siluria Technologies
- Sols
- Transphorm
- Visterra
- Vium
See also
References
- ↑ Fickenscher, Lisa (2003). "2003 40 Under 40". Crain's New York Business. Jan 27 - Feb 2, 2003: 15–31. ISSN 8756-789X. OCLC 11620213.
- ↑ Eden, Scott (2009). "Nano Wunderkinds". Dealmaker. December/January 2009: 35–37. ISSN 1937-304X. OCLC 132936538.
- ↑ Kosoff, Maya (2 April 2015). "Venture firm Lux just got $350 million more to invests in robots, the future, and science". Business Insider. Retrieved 8 June 2015.
- ↑ de la Merced, Michael (2 April 2015). "Lux Capital Raises $350 Million Fund to Back Science Start-Ups". New York Times. Retrieved 8 June 2015.
- 1 2 "Our Story". Lux Website. 14 June 2015.
- ↑ "James Woolsey and Richard Foster Join Lux Capital as Venture Partners". Business Wire. 26 April 2011.
- ↑ "Kindler, Former Pfizer Chief, Joins Lux Capital". Dealbook. 8 August 2012.